Tirelizumab in Combination With Chemoradiation in Patients With Unresectable Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
Clinical trial NCT05528367 · UNKNOWN
Trial details
- NCT number
- NCT05528367
- Sponsor
- Zhejiang Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-01
- Primary completion
- 2024-06-30
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.